The world has been transfixed by stories of gene edited babies. Genome editing is a transformative technology that needs far less sophisticated training and facilities than earlier forms of genetic engineering. It has enormous potential, including adapting crops to climate change, treating cancer and curing debilitating diseases. But its potential for accidental or deliberate misuse has led to a global debate about ethics and governance.
 
Joining us to discuss these challenges and related issues will be R. Alta Charo, J.D., the Warren P. Knowles Professor of Law & Bioethics at the University of Wisconsin and the 2019-2020 Berggruen Fellow at Stanford’s Center for Advanced Studies in Behavioral Sciences. She co-chaired the National Academy of Sciences committee on genome editing, serves on the recently created World Health Organization’s expert advisory committee on genome editing governance, and is a member of the NTI | bio Advisory Group.